Srivastava, A. K., Hollingshead, M. G., Govindharajulu, J. P., Covey, J. M., Liston, D., Simpson, M. A., . . . Parchment, R. E. (2018). Molecular Pharmacodynamics-Guided Scheduling of Biologically Effective Doses: A Drug Development Paradigm Applied to MET Tyrosine Kinase Inhibitors. Mol Cancer Ther.
Chicago-stil citatSrivastava, Apurva K., et al. "Molecular Pharmacodynamics-Guided Scheduling of Biologically Effective Doses: A Drug Development Paradigm Applied to MET Tyrosine Kinase Inhibitors." Mol Cancer Ther 2018.
MLA-referensSrivastava, Apurva K., et al. "Molecular Pharmacodynamics-Guided Scheduling of Biologically Effective Doses: A Drug Development Paradigm Applied to MET Tyrosine Kinase Inhibitors." Mol Cancer Ther 2018.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.